CLIN
Marisa Desimone, MD
Internal Medicine
SUNY Upstate Medical University
Amir Moheet
Medicine
University of Minnesota
This session will address the evolving understanding of diabetes in the changing cystic fibrosis population. Topics will include the genetic link between type 2 diabetes and cystic fibrosis related diabetes (CFRD), the role of insulin resistance, the impact of highly effective modulator therapy and the use of type 2 diabetes medications to treat CFRD.
Speaker: Scott M. Blackman, MD, PhD – Johns Hopkins University
Speaker: Remi Rabasa-Lhoret – Montreal Clinical Research Institute (IRCM); Université de Montréal; Centre Hospitalier de Université de Montréal;
Speaker: Amir Moheet – University of Minnesota
Speaker: Marisa Desimone, MD – SUNY Upstate Medical University